QXO (QXO) had the highest return between July 1, 2023 and January 31, 2024 by a mid-cap US stock, returning 303.8%.
| ASSET | DATE | % RETURN |
|---|---|---|
QXO (QXO) | 7/1/2023 - 1/31/2024 | 303.76% |
Trump Media & Technology (DJT) | 7/1/2023 - 1/31/2024 | 202.15% |
Longboard Pharmaceuticals (LBPH) | 7/1/2023 - 1/31/2024 | 199.15% |
Abercrombie & Fitch (ANF) | 7/1/2023 - 1/31/2024 | 170.94% |
Rhythm Pharmaceuticals (RYTM) | 7/1/2023 - 1/31/2024 | 167.5% |
United States Cellular (USM) | 7/1/2023 - 1/31/2024 | 153.28% |
Alpha Metallurgical Resources (AMR) | 7/1/2023 - 1/31/2024 | 142.25% |
Cytokinetics (CYTK) | 7/1/2023 - 1/31/2024 | 141.37% |
Telephone and Data Systems (TDS) | 7/1/2023 - 1/31/2024 | 136.24% |
Edgewise Therapeutics (EWTX) | 7/1/2023 - 1/31/2024 | 134.3% |
Uranium Energy (UEC) | 7/1/2023 - 1/31/2024 | 128.74% |
Vera Therapeutics (VERA) | 7/1/2023 - 1/31/2024 | 127.06% |
Camtek (CAMT) | 7/1/2023 - 1/31/2024 | 118.65% |
Gap (GAP) | 7/1/2023 - 1/31/2024 | 115.48% |
Modine Manufacturing (MOD) | 7/1/2023 - 1/31/2024 | 107.73% |
Compania de Minas Buenaventura SAA ADR (BVN) | 7/1/2023 - 1/31/2024 | 104.72% |
Crinetics Pharmaceuticals (CRNX) | 7/1/2023 - 1/31/2024 | 102.78% |
Apogee Therapeutics, Inc Common Stock (APGE) | 7/1/2023 - 1/31/2024 | 97.06% |
Powell Industries (POWL) | 7/1/2023 - 1/31/2024 | 96.89% |
Arcellx (ACLX) | 7/1/2023 - 1/31/2024 | 96.75% |
BridgeBio Pharma (BBIO) | 7/1/2023 - 1/31/2024 | 96.73% |
Pactiv Evergreen (PTVE) | 7/1/2023 - 1/31/2024 | 96.62% |
Dyne Therapeutics (DYN) | 7/1/2023 - 1/31/2024 | 92.97% |
Immunovant (IMVT) | 7/1/2023 - 1/31/2024 | 92.24% |
New Oriental Education & Technology (EDU) | 7/1/2023 - 1/31/2024 | 91.41% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
